These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

835 related items for PubMed ID: 17202110

  • 21. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina.
    Villanueva G, Sampor C, Moreno F, Alderete D, Moresco A, Pinto N, Szijan I, Schaiquevich P, Felice MS, Rose A, Zubizarreta P, Sgroi M, Fandiño A, Chantada G.
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29710. PubMed ID: 35451226
    [Abstract] [Full Text] [Related]

  • 22. Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program.
    Kutsenko A, Berrington de Gonzalez A, Curtis RE, Rajaraman P.
    Cancer Causes Control; 2014 Jun; 25(6):659-68. PubMed ID: 24682745
    [Abstract] [Full Text] [Related]

  • 23. Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review.
    Kirova YM, Vilcoq JR, Asselain B, Sastre-Garau X, Fourquet A.
    Cancer; 2005 Aug 15; 104(4):856-63. PubMed ID: 15981282
    [Abstract] [Full Text] [Related]

  • 24. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk.
    Abramson DH, Frank CM.
    Ophthalmology; 1998 Apr 15; 105(4):573-9; discussion 579-80. PubMed ID: 9544627
    [Abstract] [Full Text] [Related]

  • 25. Risks of second malignancies after breast cancer treatment: Long-term results.
    Bazire L, De Rycke Y, Asselain B, Fourquet A, Kirova YM.
    Cancer Radiother; 2017 Feb 15; 21(1):10-15. PubMed ID: 28034681
    [Abstract] [Full Text] [Related]

  • 26. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Pal HJ, Loonen JJ, Bresters D, Versluys B, Neggers SJCMM, Jaspers MWM, Hauptmann M, van der Heiden-van der Loo M, Visser O, Kremer LCM, Ronckers CM, DCOG LATER Study Group.
    J Clin Oncol; 2017 Jul 10; 35(20):2288-2298. PubMed ID: 28530852
    [Abstract] [Full Text] [Related]

  • 27. Second cranio-facial malignancies in hereditary retinoblastoma survivors previously treated with radiation therapy: clinic and radiologic characteristics and survival outcomes.
    Rodjan F, Graaf Pd, Brisse HJ, Verbeke JI, Sanchez E, Galluzzi P, Göricke S, Maeder P, Aerts I, Dendale R, Desjardins L, de Franscesco S, Bornfeld N, Sauerwein W, Popovic MB, Knol DL, Moll AC, Castelijns JA.
    Eur J Cancer; 2013 May 10; 49(8):1939-47. PubMed ID: 23415887
    [Abstract] [Full Text] [Related]

  • 28. Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort study.
    Veiga LHS, Vo JB, Curtis RE, Mille MM, Lee C, Ramin C, Bodelon C, Aiello Bowles EJ, Buist DSM, Weinmann S, Feigelson HS, Gierach GL, Berrington de Gonzalez A.
    Lancet Oncol; 2022 Nov 10; 23(11):1451-1464. PubMed ID: 36240805
    [Abstract] [Full Text] [Related]

  • 29. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC, Spinelli JJ, Rogers PC, Goddard KJ, Phillips N, McBride ML.
    Pediatr Blood Cancer; 2007 Apr 10; 48(4):453-9. PubMed ID: 16767718
    [Abstract] [Full Text] [Related]

  • 30. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
    Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Pukkala E, Lynch CF, Pee D, Smith SA, Van't Veer MB, Joensuu T, Storm H, Stovall M, Boice JD, Gilbert E, Gail MH.
    J Natl Cancer Inst; 2005 Oct 05; 97(19):1428-37. PubMed ID: 16204692
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment.
    Rubino C, Shamsaldin A, Lê MG, Labbé M, Guinebretière JM, Chavaudra J, de Vathaire F.
    Breast Cancer Res Treat; 2005 Feb 05; 89(3):277-88. PubMed ID: 15754127
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries.
    Zhu G, Chen Y, Zhu Z, Lu L, Bi X, Deng Q, Chen X, Su H, Liu Y, Guo H, Zheng T, Yu H, Zhang Y.
    Dis Esophagus; 2012 Aug 05; 25(6):505-11. PubMed ID: 22067063
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.